this reduction was more evident amongst women with a diagnosis of carcinoma-in-situ ( mean 213.1 micrograms l-1 than amongst those with severe dysplasia ( mean 228.7 micrograms l-1 .
C0007099
carcinoma-in-situ
C0334048
severe